Cargando…

NAT2 Genotype and Isoniazid Medication in Children

Detalles Bibliográficos
Autores principales:	Golka, Klaus, Selinski, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049983/ https://www.ncbi.nlm.nih.gov/pubmed/27591833 http://dx.doi.org/10.1016/j.ebiom.2016.08.040

Ejemplares similares

Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients
por: Toure, A., et al.
Publicado: (2016)

The Influence of NAT2 Genotypes on Isoniazid Plasma Concentration of Pulmonary Tuberculosis Patients in Southern Thailand
por: Ungcharoen, Usanee, et al.
Publicado: (2020)

The Non-Linear Child: Ontogeny, Isoniazid Concentration, and NAT2 Genotype Modulate Enzyme Reaction Kinetics and Metabolism
por: Rogers, Zoe, et al.
Publicado: (2016)

Isoniazid Concentration and NAT2 Genotype Predict Risk of Systemic Drug Reactions during 3HP for LTBI
por: Lee, Meng-Rui, et al.
Publicado: (2019)

Study of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit
por: Birch Kristensen, Emilie, et al.
Publicado: (2018)

Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients
por: Chan, Sze Ling, et al.
Publicado: (2017)

Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy – case report and literature review
por: Constantinescu, Stefan Matei, et al.
Publicado: (2017)

Influence of N-acetyltransferase 2 (NAT2) genotype/single nucleotide polymorphisms on clearance of isoniazid in tuberculosis patients: a systematic review of population pharmacokinetic models
por: Thomas, Levin, et al.
Publicado: (2022)

NAT2 gene polymorphism: covert drug interaction causing phenytoin toxicity
por: Adithan, C., et al.
Publicado: (2016)

Editorial: Biomarkers in Drug Hypersensitivity
por: Agúndez, José A. G., et al.
Publicado: (2017)

Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence
por: Khan, Saif, et al.
Publicado: (2019)

A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype
por: Kuznetsov, Igor B., et al.
Publicado: (2009)

Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers
por: Schwender, Holger, et al.
Publicado: (2012)

Correction: Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers
por: Schwender, Holger, et al.
Publicado: (2015)

Studying polymorphic variants of the NAT2 gene (NAT2*5 and NAT2*7) in Nenets populations of Northern Siberia
por: Tiis, Roza Pavlovna, et al.
Publicado: (2020)

Worldwide distribution of NAT2 diversity: Implications for NAT2 evolutionary history
por: Sabbagh, Audrey, et al.
Publicado: (2008)

N-Acetyltransferase-2 (NAT2) phenotype is influenced by genotype-environment interaction in Ethiopians
por: Aklillu, Eleni, et al.
Publicado: (2018)

Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancer
por: Huang-Tiel, Hui-Juan, et al.
Publicado: (2020)

With respect to Nat
Publicado: (1966)

NAT2 genotype guided regimen reduces isoniazid-induced liver injury and early treatment failure in the 6-month four-drug standard treatment of tuberculosis: A randomized controlled trial for pharmacogenetics-based therapy
por: Azuma, Junichi, et al.
Publicado: (2012)

Isoniazid Preventive Therapy and Pregnancy Outcomes in Women Living With Human Immunodeficiency Virus in the Tshepiso Cohort
por: Salazar-Austin, Nicole, et al.
Publicado: (2019)

N-Acetyltransferase 2 Genotypes among Zulu-Speaking South Africans and Isoniazid and N-Acetyl-Isoniazid Pharmacokinetics during Antituberculosis Treatment
por: Mthiyane, Thuli, et al.
Publicado: (2020)

Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype
por: Tóth, Katalin, et al.
Publicado: (2016)

Evaluating NAT2PRED for inferring the individual acetylation status from unphased genotype data
por: Sabbagh, Audrey, et al.
Publicado: (2009)

Distribution of allelic and genotypic frequencies of NAT2 and CYP2E1 variants in Moroccan population
por: Guaoua, Soukaina, et al.
Publicado: (2014)

Study on Genotyping Polymorphism and Sequencing of N-Acetyltransferase 2 (NAT2) among Al-Ahsa Population
por: Zahra, Mohammad Abu, et al.
Publicado: (2020)

Correlation of N-Acetyltransferase 2 Genotype with Isoniazid Acetylation in Polish Tuberculosis Patients
por: Zabost, Anna, et al.
Publicado: (2013)

Allelic and genotypic frequencies of NAT2, CYP2E1, and AADAC genes in a cohort of Peruvian tuberculosis patients
por: Levano, Kelly S., et al.
Publicado: (2021)

Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer
por: Ecke, Thorsten H., et al.
Publicado: (2016)

Is NAT2 Gene Polymorphism Associated with Vitiligo?
por: Srivastava, Daya Shankar Lal, et al.
Publicado: (2020)

Haplotype-specific PCR for NAT2 diplotyping
por: Wichukchinda, Nuanjun, et al.
Publicado: (2020)

Single-track sequencing for genotyping of multiple SNPs in the N-acetyltransferase 1 (NAT1) gene
por: Soucek, Pavel, et al.
Publicado: (2004)

German Language Adaptation of the NAVS (NAVS-G) and of the NAT (NAT-G): Testing Grammar in Aphasia
por: Ditges, Ruth, et al.
Publicado: (2021)

Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women
por: McGrath, Monica, et al.
Publicado: (2006)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Arylamine N-acetyltransferase 2 genotype-dependent N-acetylation of isoniazid in cryopreserved human hepatocytes
por: Doll, Mark A., et al.
Publicado: (2017)

Interaction between Red Meat Intake and NAT2 Genotype in Increasing the Risk of Colorectal Cancer in Japanese and African Americans
por: Wang, Hansong, et al.
Publicado: (2015)

Multi-Institutional Implementation of Clinical Decision Support for APOL1, NAT2, and YEATS4 Genotyping in Antihypertensive Management
por: Schneider, Thomas M., et al.
Publicado: (2021)

Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis
por: Rens, Neil E, et al.
Publicado: (2020)

Pharmacokinetics and Safety of 3 Months of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention in Pregnant Women
por: Mathad, Jyoti S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_km1e5v5snmpe8c3nd8s6fqpih6